References
- Eudy AE, Gordon LL, Hockaday BC, Lee DA, Lee V, Luu D, et al. Efficacy and safety of ingredients found in preworkout supplements. Am J Health Syst Pharm 2013; 70:577–588.
- Dwyer JT, Allison DB, Coates PM. Dietary supplements in weight reduction. J Am Diet Assoc 2005; 105:S80–S86.
- Haller CA, Duan M, Benowitz NL, Jacob P III. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements. J Anal Toxicol 2004; 28:145–151.
- Ottaviano V, Furnari C, Rosati F. Identification of di(beta-phenylisopropyl)amine as the main ingredient in illicit amphetamine tablets. Ann Ist Super Sanita 2002; 38:331–335.
- Ketema H, Davis WM, Walker LA, Borne RF. Pharmacologic and toxicologic effects of di(beta-phenylisopropyl)amine (DPIA) in rats and mice. Gen Pharmacol 1990; 21:783–790.
- Carvalho M, Carmo H, Costa VM, Capela JP, Pontes H, Remião F, et al. Toxicity of amphetamines: an update. Arch Toxicol 2012; 86:1167–1231.
- Barceloux DG. Medical toxicology of drug abuse. Synthesized chemicals and psychoactive plants. Hoboken, NJ: John Wiley & Sons, Inc.; 2012:3–56.
- Netherlands Food and Consumer Product Safety Authority (NVWA). Accessed date: 20 October 2013 http://www.vwa.nl/actueel/nieuws/nieuwsbericht/2031981/